Indicators Affecting PVT Recanalization
Recruiting · NCT07473375 · Observational (researchers observe without assigning treatment) · Lead sponsor: Shanghai Zhongshan Hospital
View the official record on ClinicalTrials.gov →What this trial is about
This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- diagnosed as cirrhosis and confirmed gastroesophageal varices by endoscopy;
- all patients were diagnosed as PVT by CTA at admission.
Exclusion criteria
- patients with hepatocellular carcinoma;
- patients with extrahepatic malignancies;
- history of liver transplantation or TIPS;
- lack of information regarding anticoagulation therapy；
- those with cavernous transformation of the portal vein(CTPV) .
Where it is running
1 location listed.
- Study site - Shanghai, Shanghai Municipality, China